SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-059558
Filing Date
2011-06-16
Accepted
2011-06-16 16:58:13
Documents
9
Period of Report
2011-06-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a59766e8vk.htm 8-K 19913
2 EX-10.1 a59766exv10w1.htm EX-10.1 763417
3 EX-10.2 a59766exv10w2.htm EX-10.2 761682
4 GRAPHIC a59766a5976601.gif GRAPHIC 50631
5 GRAPHIC a59766a5976602.gif GRAPHIC 57108
6 GRAPHIC a59766a5976603.gif GRAPHIC 83546
7 GRAPHIC a59766a5976605.gif GRAPHIC 60916
8 GRAPHIC a59766a5976604.gif GRAPHIC 39472
9 GRAPHIC a59766a5976606.gif GRAPHIC 165734
  Complete submission text file 0000950123-11-059558.txt   2177362
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 11915612
SIC: 2836 Biological Products, (No Diagnostic Substances)